Právní předpis byl sestaven k datu 07.04.2026.
Zobrazené znění právního předpisu je účinné od 10.12.2024.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2025
375/2024 Sb.
375
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 5. xxxxxxxx 2024
o xxxxxxxxxx xxxxxxx očkovacích xxxxx pro pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2025
&xxxx;
Xxxxxxxxxxxx zdravotnictví xxxxx §80 odst. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx souvisejících xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační xxxxxx xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro rok 2025:
1. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx látka proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Haemophilus influenzae xxx b (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx méně xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx méně než 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Bordetelly pertussis:
Pertussis xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx filamentosum (XXX)1 25 xxxxxxxxxx
Xxxxxxxxxxx (XXX)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X (XXx)2,3 10 mikrogramů
Virus xxxxxxxxxxxxxxx inactivatum (XXX)
xx xxx 1 (kmen Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X jednotek xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae xxxxx x polysaccharidum
(Polyribosylribitoli xxxxxxxx) 10 xxxxxxxxxx
xxxx. cum xxxxxx. xxxxxxxx jako xxxxx protein xxxxxxxxx 25 mikrogramů
1 adsorbováno xx hydroxid xxxxxxx, xxxxxxxxxxx (Al(OH)3) 0,5 xxxxxxxxx Xx3+
2 xxxxxxxx xxxxxxxxxxxxx DNA technologií xx xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx cerevisiae)
3 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (AlPO4) 0,32 xxxxxxxxx Al3+
4 xxxxxxxxx xx VERO xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) obsahuje:
Diphtheriae anatoxinum xx xxxx xxx 20 mezinárodních jednotek (XX)2,4 (30 Xx)
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)3,4 (10 Xx)
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Poliomyelitidis (xxxxxxxxxxxx)5
xxxxx 1 (Xxxxxxx) 29 X xxxxxxxx xxxxxxxx6
xxxxx 2 (XXX-1) 7 X jednotek xxxxxxxx6
xxxxx 3 (Xxxxxxx) 26 X xxxxxxxx xxxxxxxx6
Xxxxxxxxx xxxxxxxxxxx X xxxxxxxxx7 10 mikrogramů
Haemophili xxxxxxxxxx xxxx B xxxxxxxxxxxxxxx (Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 12 xxxxxxxxxx coniugatum cum xxxxxx proteino 22-36 xxxxxxxxxx
1 Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Al3+)
2 Xxxx xxxxxx xxx xxxxxxxxxxxxx (p = 0,95) x xx xxxx než 30 XX xxxx střední xxxxxxx
3 Jako spodní xxx xxxxxxxxxxxxx (x = 0,95)
4 Xxxx xxxxxxxxxxxx xxxxxxxx stanovená xxxxxxxxxx xxxxxxxxxxx
5 Xxxxxxxxxxx xx Xxxx buňkách
6 Xxxx xxxxxxxx antigenu xxxx xxxxx stejná xxxx ta, xxxxx xxxx xxxxx vyjádřená xxxx 40-8-32 D xxxxxxxx xxxxxxxx pro xxxxx xxxx 1, 2 a 3, xxx měření xxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
7 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx v xxxxxxxxxxxx xxxxxxx Hansenula xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx záškrtu, xxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (rDNA), xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus typu x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 ml) obsahuje:
Diphtheriae xxxxxxxxxx1 xx méně xxx 20 XX6
Xxxxxx xxxxxxxxxx1 xx méně xxx 40 XX6
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 20 xxxxxxxxxx
Xxxxxxxxxxx (PRN) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (FIM) 5 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx X 2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Mahoney) 40 D jednotek xxxxxxxx5
Xxxxx 2 (XXX-1) 8 D xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Haemophili influenzae xxxxx x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx xxx proteinům xxxxxxxxxxxx xxxxx x2 50 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 xx Xx3+)
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 xxxxxxxx xxxxxxxxxxxxx DNA technologií x xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 xxxxxxxxx xx Vero xxxxxxx
5 xxxx ekvivalentní množství xxxxxxxx stanovené xxxxxxx xxxxxxxxxxxxxx xxxxxxx
6 xxxx xxxxxxxxxxxx aktivita xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX)
Xxxxx xxxxx (0,5 ml) xxxxxxxx xxxx léčivé xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 IU
Pertussis xxxxxxxxxx* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69xX) 8 xxxxxxxxxx
* xxxxxxxxxxx xx hydroxid xxxxxxx celkem: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, tetanu x xxxxxxxx xxxxx (xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Tdap)
Jedna xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 IU* (2 Lf)
Tetani anatoxinum - Xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 mikrogramů
Haemagglutinum filamentosum - 5 mikrogramů
Pertactinum - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Jako xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (X1(XX)3) 0,3 xxxxxxxxx Xx3+ x fosforečnan xxxxxxx (AlPO4) 0,2 xxxxxxxxx Al3+
1c) očkovací xxxxx proti xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b:
Po xxxxxxxxxxxx 1 dávka (0,5 xx) obsahuje:
Haemophilus xxxxxxxxxx xxxxx x xxxx xxxxxxxxxxx 10 xxxxxxxxxx
xxxxxxxxxxx x tetanickým toxoidem xxxx xxxxxxxxxxx nosičem xxxxxxxxx 25 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx xxxxxxxxxx - min. 40 mezinárodních jednotek
1e) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B x xxxxxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 mikrogramů
1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B x xxxxxxx formuli
Jedna dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 20 xxxxxxxxxx
1x) očkovací xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx:
xxxxx xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 infekční xxxxx pro buněčnou xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx pro buněčnou xxxxxxx503
1 xxxxxxxxx na xxxxxxx xxxxxxxx embryí
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% infekční xxxxx xxxxxxx kultury
NEBO
1ga) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx jedna xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Enders’ Xxxxxxxxx) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Xxxxx Lynn™, hladina X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx attenuatum (xxxx Wistar RA 27/3) ne xxxx xxx 1x103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx kultury
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx v xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxx xxxxxxxxxxxxx inactivatum typus 1 (Xxxxxxx) ... 29 antigenních X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (XXX-1) ... 7 xxxxxxxxxxx X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ) ... 26 antigenních X xxxxxxxx**
* Kultivováno xx XXXX xxxxxxx
** Xxxx xxxxxxxx xxxxxxxx xxxx xxxxx xxxxxx xxxx xx, která xxxx xxxxx xxxxxxxxx xxxx 40-8-32 X xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx xxxxxx jinou xxxxxxx xxxxxxxxxxxxxx xxxxxxx
1xx) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxxxxxxxx xxxxxxxx
Xxxxx xxxxx (0,5 xx) obsahuje:
Polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 1 1,2 2,2 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 3 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 4 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 5 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 6A 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx sérotypu 6X 1,2 4,4 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 7X 1,2 2,2 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx sérotypu 8 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9 X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae sérotypu 10X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 12X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 14 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 15X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 18X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 22X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 23X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 33X 1,2 2,2 µx
1 Xxxxxxxxxx s xxxxxx xxxxxxxxx CRM197 (xxxxxxxxx 51 µg xx xxxxx)
2 Xxxxxxxxxx xx fosforečnan xxxxxxx (0,125 xx xxxxxxx xx xxxxx)
XXXX
1xxx) očkovací xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx používané x xxxxxxxxxx xxxxxxxx:
1xxxx) konjugovaná xxxxxxxx xxxxx obsahuje:
Streptococci xxxxxxxxxx xxxxxxxx 11,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 31,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 41,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 51,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 6A1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6X1,2 xxxxxxxxxxxxxxx 4,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 7X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 9X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 141,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 19X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx sérotypu 19X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 22X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 23F1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 33X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
1 Xxxxxxxxxx x proteinovým xxxxxxx CRM197, XXX197 xx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxxx (xxxxxxxxxxxxx x Xxxxxxxxxxxxxxx xxxxxxxxxxx X7) xxxxxxxxxxxxx xxxxxxxxxxxxx x Xxxxxxxxxxx xxxxxxxxxxx
2 Xxxxxxxxxx xx adjuvans xxxxxxxxxxx hlinitý
A
1chab) xxxx xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9X, 10X, 11X, 12X, 14, 15B, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X
XXXX
1xxx) xxxxxxxx xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxxxxx xxxxxxxx:
1xxxx) xxxxxxxxxxx očkovací xxxxx xxxxxxxx:
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx s xxxxxx xxxxxxxxx XXX197 x xxxxxxxxxx na xxxxxxxxxxx xxxxxxx (0,125 xx hliníku)
A
1chbb) póly xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23F, 33X
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1-&xxxx; xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx pertussis antigena:
Pertussis xxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (kmen Xxxxxxx)2 40 X xxxxxxxx antigenu
typus 2 (xxxx XXX-1)2 8 X xxxxxxxx antigenu
typus 3 (xxxx Saukett)2 32 X xxxxxxxx xxxxxxxx
1 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 miligramu Xx3+ x fosforečnan xxxxxxx (AlPO4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx 2 XX1 (2 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 XX1 (5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (inactivatum)2
typus 1 (Xxxxxxx) 29 X xxxxxxxx xxxxxxxx3
xxxxx 2 (MEF1) 7 X xxxxxxxx antigenu3
typus 3 (Xxxxxxx) 26 X jednotek xxxxxxxx3
Xxxxxxxxxxx xx fosforečnan xxxxxxx 1,5 xx (0,33 xx Xx3+)
1 Jako xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx
2 Xxxxxxxxxxx na Xxxx xxxxxxx
3 Xxxx xxxxxxxx xxxxxxxx xxxx xxxxx xxxxxx xxxx ta, xxxxx byla xxxxx xxxxxxxxx xxxx 40-8-32 X xxxxxxxx antigenu xxx virus typu 1, 2 x 3, xxx xxxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
* Xxxx spodní xxxxxxx intervalu spolehlivosti (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx
** Xxxxxxxxxxx xx Xxxx buňkách.
1j) xxxxxxxx látka xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx (0,5 ml) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 adjuvovaný xx AS04C xxxxxxxxxx: - 3-O-deacyl-4'-monofosforyl-lipid X (XXX)2 50 mikrogramů
2 xxxxxxxxxxx xx fosforečnan xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx xx xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx cerevisiae) xxxxxxxxxxxxx XXX xxxxxxxxxxx.
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 20 xxxxxxxxxx
2x) očkovací látka xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx obsahuje:
Hepatitis A xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx proti spalničkám, xxxxxxxxxx x xxxxxxxxx:
1 xxxxx xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx diploidních xxxxxxx (MRC-5)
3 50% xxxxxxxx dávka tkáňové xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x zarděnkám
Po xxxxxxxxxx xxxxxxxx xxxxx dávka (0,5 xx):
Xxxxx morbillorum1 xxxxx attenuatum (xxxx Xxxxxx’ Edmonston) xx xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (kmen Jeryl Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 CCID50*
Virus xxxxxxxx2 xxxxx attenuatum (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx lidských xxxxxxxxxxx xxxxxxx XX-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxx očkování
3a) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx X inactivatum
3b) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
1 dávka xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) obsahuje:
Morbillorum virus xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx na xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx látka proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx morbillorum1 xxxxx xxxxxxxxxx (kmen Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Wistar XX 27/3) ne xxxx než 1x1103 XXXX50*
* 50% xxxxxxxx xxxxx buněčné xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx xxxxxxxx diploidních xxxxxxxx XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, XXx., XXX, EBIR, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 375/2024 Xx. xxxxx xxxxxxxxx dnem 10.12.2024.
Xx xxx xxxxxxxx nebyl xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud se xxxx netýká xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.